| |
| |
|
| Insider
Information: |
Formela Jean Francois |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
7,291 |
|
|
Indirect Shares
|
24,762,873 |
|
|
| Direct
Value |
$190,805 |
|
|
|
Indirect Value
|
$273,064,457 |
|
|
| Total
Shares |
24,770,164 |
|
|
| Total
Value |
$273,255,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 179.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Decode Genetics Inc |
DCGN |
Director |
2003-09-09 |
0 |
2003-12-11 |
0 |
Premium* |
|
|
Exelixis Inc |
EXEL |
Director |
2003-11-13 |
0 |
2005-09-07 |
584,519 |
Premium* |
|
|
Nxstage Medical, Inc. |
NXTM |
Director, 10% Owner |
|
0 |
2006-05-26 |
2,592,126 |
Premium* |
|
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director, 10% Owner |
2006-02-01 |
0 |
2006-02-06 |
2,485,068 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
Director, 10% Owner |
2006-10-31 |
0 |
2006-10-31 |
1,968,670 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
Director, 10% Owner |
|
0 |
2012-10-22 |
1,579,542 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director, 10% Owner |
|
0 |
2011-08-02 |
5,393,178 |
Premium* |
|
|
Egalet Corp |
EGLT |
Director, 10% Owner |
|
0 |
2014-02-11 |
2,460,949 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2022-06-14 |
7,291 |
2021-06-28 |
10,000 |
Premium* |
|
|
Spero Therapeutics Inc |
SPRO |
Director |
2017-11-06 |
0 |
2017-11-06 |
2,408,128 |
Premium* |
|
|
Translate Bio, Inc. |
TBIO |
Director |
2018-07-02 |
0 |
2021-09-14 |
0 |
Premium* |
|
|
Ikena Oncology, Inc. |
IKNA |
Director |
|
0 |
2021-12-14 |
4,143,544 |
Premium* |
|
|
Korro Bio |
KRRO |
|
2023-11-03 |
0 |
2024-04-22 |
1,137,149 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-12-11 |
4 |
S |
$8.14 |
$159,570 |
I/I |
(19,610) |
0 |
|
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2017-03-10 |
4 |
S |
$14.06 |
$77,410 |
I/I |
(5,504) |
0 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2018-03-20 |
4 |
S |
$23.78 |
$936,743 |
I/I |
(39,245) |
0 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2018-05-16 |
4 |
AS |
$25.04 |
$167,389 |
I/I |
(6,686) |
0 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2018-06-19 |
4 |
AS |
$27.84 |
$186,908 |
I/I |
(6,686) |
0 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2018-07-16 |
4 |
AS |
$30.97 |
$208,397 |
I/I |
(6,686) |
0 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
Director |
– • – |
2021-09-14 |
4 |
AS |
$38.00 |
$78,092,394 |
I/I |
(2,055,063) |
0 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,094 |
2,094 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2017-03-09 |
4 |
S |
$13.85 |
$216,432 |
I/I |
(15,628) |
5,504 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,197 |
7,291 |
0 |
- |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-24 |
4 |
S |
$5.09 |
$889,998 |
I/I |
(175,000) |
7,791 |
|
- |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-10-01 |
4 |
S |
$5.00 |
$125,100 |
I/I |
(25,000) |
9,805 |
|
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-06-28 |
4 |
AS |
$127.02 |
$73,448,879 |
I/I |
(553,376) |
10,000 |
0 |
% |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-30 |
4 |
S |
$4.91 |
$490,760 |
I/I |
(100,000) |
22,305 |
|
- |
|
| TBIO |
Translate Bio, Inc. |
Director |
– • – |
2020-12-22 |
4 |
AS |
$25.04 |
$2,069,870 |
I/I |
(82,565) |
43,940 |
0 |
% |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-26 |
4 |
S |
$4.22 |
$280,956 |
I/I |
(66,500) |
72,305 |
|
- |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-23 |
4 |
S |
$4.41 |
$882,280 |
I/I |
(200,000) |
95,291 |
|
- |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-25 |
4 |
S |
$4.83 |
$196,100 |
I/I |
(40,582) |
105,555 |
|
- |
|
| NXTM |
Nxstage Medical, Inc. |
Director |
– • • |
2005-10-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
119,022 |
|
- |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-25 |
4 |
D |
$18.00 |
$250,020 |
I/I |
(13,890) |
125,846 |
|
- |
|
| TBIO |
Translate Bio, Inc. |
Director |
– • – |
2020-12-21 |
4 |
AS |
$25.50 |
$1,441,928 |
I/I |
(56,536) |
126,505 |
0 |
% |
|
| DCGN |
Decode Genetics Inc |
Director |
– • – |
2003-09-25 |
4 |
OE |
$1.00 |
$250,000 |
I/I |
250,000 |
132,791 |
|
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
169,095 |
|
- |
|
| KRRO |
Korro Bio |
|
– • – |
2023-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,119,292 |
177,217 |
0 |
- |
|
| KRRO |
Korro Bio |
|
– • – |
2024-04-22 |
4 |
A |
$56.00 |
$999,992 |
I/I |
17,857 |
195,074 |
0 |
- |
|
96 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
